AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
LONDON and PHOENIX, April 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc.…
Kia collaborates with Bcomp, Simplifyber and Biomyc, bringing innovative components to Kia Concept EV2
Partnership with Bcomp reduces environmental impact through implementation of Swiss company’s innovative…
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class…
NordVPN undergoes independent security assessment, reinforcing security and privacy commitment
LONDON, March 07, 2025 (GLOBE NEWSWIRE) -- NordVPN, a cybersecurity company, has…
Carahsoft Recognized as Institute of Excellence in Sales Premier Sales Employer for 2024
RESTON, Va., March 05, 2025 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp., The…
KFSHRCs Dr. Jackie Ying Named in Forbes 50 Over 50 Global 2025 List
RIYADH, Saudi Arabia, March 04, 2025 (GLOBE NEWSWIRE) -- Dr. Jackie Ying,…
Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results
Accelerated execution of Phase 2 APEX clinical trial for APG777, with Part…
Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)
Interim Phase 1 results for APG990, a novel half-life extended OX40L antibody,…
New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
A 9.7-month median progression-free survival (mPFS) was reached for the 50mg twice-daily…
Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial Fibrillation
February 14, 2025 05:30 ET | Source: Volta Medical AI-Guided Cardiac Ablation…